Antimicrobial Use Control Measures to Prevent and Control Antimicrobial Resistance in US Hospitals | Infection Control & Hospital Epidemiology | Cambridge Core (original) (raw)

References

  1. Carmeli, Y, Troillet, N, Karchmer, AW, Samore, MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa . Arch Intern Med 1999; 159:1127–1132.CrossRefGoogle ScholarPubMed

  2. Institute of Medicine (IOM). To Err Is Human: Building a Safer Health System. Kohn, LT, Corrigan, JM, Donaldson, M, eds. Washington, DC: Committee on Quality of Health Care in America, IOM, 2000.Google Scholar

  3. Center for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001; 29:404–421.CrossRefGoogle Scholar

  4. Diekema, DJ, Pfaller, MA, Schmitz, FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S114–S132.CrossRefGoogle ScholarPubMed

  5. Fridkin, SK, Steward, CD, Edwards, JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29:245–252.CrossRefGoogle ScholarPubMed

  6. John, JF Jr, Fishman, NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997;24:471–485.CrossRefGoogle ScholarPubMed

  7. Healthy People 2010 Immunizations and Infectious Diseases. Washington, DC: US Department of Health and Human Services, Office of Public Health and Science; 2000:14–1 to 14-59.Google Scholar

  8. Goldmann, DA, Weinstein, RA, Wenzel, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234–240.CrossRefGoogle ScholarPubMed

  9. Shlaes, DM, Gerding, DN, John, JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584–599.CrossRefGoogle Scholar

  10. Murthy, R. Implementation of strategies to control antimicrobial resistance. Chest 2001;119(Suppl 2):405S–411S.CrossRefGoogle ScholarPubMed

  11. Gross, PA, Pujat, D. Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Med Care 2001; 39(Suppl 2):II-55–II-69.CrossRefGoogle ScholarPubMed

  12. Gould, IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999; 43:459–465.CrossRefGoogle ScholarPubMed

  13. Parrino, TA. Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004. Pharmacotherapy 2005; 25:289–298.CrossRefGoogle ScholarPubMed

  14. Wilton, P, Smith, R, Coast, J, Millar, M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. J Health Serv Res Policy 2002; 7:111–117.CrossRefGoogle ScholarPubMed

  15. Ward, MM, Diekema, DJ, Yankey, JW, et al. Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in US hospitals. Infect Control Hosp Epidemiol 2005; 26:21–30.CrossRefGoogle Scholar

  16. Flach, SD, Diekema, DJ, Yankey, JW, et al. Variation in the use of procedures to monitor antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol 2005; 26:31–38.CrossRefGoogle Scholar

  17. Field, TS, Cadoret, CA, Brown, ML, et al. Surveying physicians: do components of the “total design approach” to optimizing survey response rates apply to physicians? Med Care 2002; 40:596–605.CrossRefGoogle ScholarPubMed

  18. Diekema, DJ, Boots Miller, BJ, Vaughn, TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004; 38:78–85.CrossRefGoogle ScholarPubMed

  19. Harbin, JW, Hilbe, JM. Generalized Estimating Equations. Boca Raton, FL: Chapman and Hall/CRC; 2002.Google Scholar

  20. Little, R, Rubin, D. Statistical Analysis with Missing Data. New York: Wiley; 1987.Google Scholar

  21. Low, DE, Keller, N, Barth, A, Jones, RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2)S133–S145.CrossRefGoogle ScholarPubMed

  22. Diekema, DJ, Pfaller, MA, Jones, RN, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999; 29:595–607.Google ScholarPubMed

  23. Jones, ME, Mayfield, DC, Thornsberry, C, Karlowsky, JA, Sahm, DF, Peterson, D. Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicrob Agents Chemother 2002; 46:3104–3105.CrossRefGoogle ScholarPubMed

  24. Karlowsky, JA, Kelly, LJ, Thornsberry, C, et al. Susceptibility to fluoroquinolones among commonly isolated gram-negative bacilli in 2000: TRUST and TSN data for the United States: tracking resistance in the united states today. The Surveillance Network. Int J Antimicrob Agents 2002; 19:21–31.CrossRefGoogle ScholarPubMed

  25. Ward, MM, Doebbeling, BN, Vaughn, TE, et al. Effectiveness of a nationally implemented smoking cessation guideline on provider and patient practices. Prev Med 2003; 36:265–271.CrossRefGoogle ScholarPubMed

  26. Ward, MM, Vaughn, TE, Uden-Holman, T, Doebbeling, BN, Clarke, WR, Woolson, RF. Physician knowledge, attitudes and practices regarding a widely implemented guideline. J Eval Clin Pract 2002; 8:155–162.CrossRefGoogle ScholarPubMed

  27. Ward, MM, Yankey, JW, Vaughn, TE, et al. Physician process and patient outcome measures for diabetes care: relationships to organizational characteristics. Med Care 2004; 42:840–850.CrossRefGoogle ScholarPubMed

  28. Bero, LA, Grilli, R, Grimshaw, JM, Harvey, E, Oxman, AD, Thomson, MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ 1998; 317:465–468.CrossRefGoogle Scholar

  29. Wakefield, DS, Pfaller, M, Massanari, RM, Hammons, GT. Variation in methicillin-resistant Staphylococcus aureus occurrence by geographic location and hospital characteristics. Infect Control 1987; 8:151–157.CrossRefGoogle ScholarPubMed

  30. Lawton, RM, Fridkin, SK, Gaynes, RP, McGowan, JE Jr. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America / Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000; 21:256–259.CrossRefGoogle ScholarPubMed

  31. Kawamoto, K, Houlihan, CA, Balas, EA, Lobach, DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005; 330:765.CrossRefGoogle ScholarPubMed

  32. Garg, AX, Adhikari, NK, McDonald, H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005; 293:1223–1238.CrossRefGoogle ScholarPubMed

  33. Fang, E, Mittman, BS, Weingarten, S. Use of clinical practice guidelines in managed care physician groups. Arch Earn Med 1996; 5:528–531.Google ScholarPubMed

  34. Newton, J, Knight, D, Woolhead, G. General practitioners and clinical guidelines: a survey of knowledge, use and beliefs. Br J Gen Pract 1996; 46:513–517.Google ScholarPubMed

  35. Wise, CG, Billi, JE. A model for practice guideline adaptation and implementation: empowerment of the physician. Jt Comm J Qual Improv 1995;21:465–476.Google Scholar

  36. Davis, DA, Thomson, MA, Oxman, AD, Haynes, RB. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA 1992; 268:1111–1117.CrossRefGoogle ScholarPubMed

  37. Lomas, J, Anderson, GM, Domnick-Pierre, K, Vayda, E, Enkin, MW, Hannah, WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989; 321:1306–1311.CrossRefGoogle ScholarPubMed

  38. Woolf, SH. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med 1993; 153:2646–2655.CrossRefGoogle Scholar

  39. Teich, J, Osheroff, J, Pifer, E, Sittig, D, Jenders, R. Clinical decision support in electronic prescribing: recommendations and an action plan, report of the Joint Clinical Decision Support Workgroup. Washington, DC; Department of Health of Human Services; 2005.Google Scholar

  40. Polk, RE. Antimicrobial formularies: can they minimize antimicrobial resistance? Am J Health Syst Pharm 2003; 60(Suppl 1):S16–S19.CrossRefGoogle ScholarPubMed

  41. Bergstrom, CT, Lo, M, Lipsitch, M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 2004; 101:13285–13290.CrossRefGoogle Scholar

  42. Landman, D, Chockalingam, M, Quale, JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062–1066.CrossRefGoogle Scholar

  43. Rahal, JJ, Urban, C, Horn, D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella . JAMA 1998; 280:1233–1237.CrossRefGoogle ScholarPubMed

  44. Regal, RE, DePestel, DD, VandenBussche, HL. The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta-lactams in a large teaching hospital. Pharmacotherapy 2003; 23:618–624.CrossRefGoogle Scholar

  45. Bantar, C, Sartori, B, Vesco, E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37:180–186.CrossRefGoogle ScholarPubMed

  46. Cook, PP, Catrou, PG, Christie, JD, Young, PD, Polk, RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 2004; 53:853–859.CrossRefGoogle ScholarPubMed

  47. Ernst, EJ, Diekema, DJ, BootsMiller, BJ, et al. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis 2004; 49:141–145.CrossRefGoogle ScholarPubMed